ALHC
Alignment Healthcare, Inc.
$19.83
-1.20 (-5.71%)
At close · Jul 10
Market Cap
$4.10B
Shares
206,733,823
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$19.83
Open$20.77
Day$19.55–20.94
52W$11.63–25.12
Avg vol 30d6.6M
Short int24.4M · 11.8% float · 4.7d
Short vol69%
Last earningsApr 30, 2026
DataMar 2021–Jul 2026
Filing10-Q · Apr 30
Up next
Next earnings call
Jul 30, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
+4%
above
Price vs 50-day avg
+4%
above
RSI (14)
45
neutral
MACD trend
Negative
52-week position
61%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−4%
trailing
6-month return
−12%
trailing
YTD return
0%
this year
Relative strength
−21%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $19 › 200d $19 — 200d above 50d
Institutional flow
Distributing
4 of 294 funds reported for Jun 30 · net -110.8K sh shares
Insider flow
Distributing
Net -$14.2M over 90 days · 75% sells
Short interest
Falling
11.79% of float · ▼ -4.1% MoM · 4.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
294 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+46%
Y/Y
EPS growth
+100%
Y/Y
Free cash flow
$113.1M
Valuation
P/E 198.3
rich
Balance sheet
$252.6M
net cash
Quant / Vol
risk profile
Volatility
58%
annualized · 1-yr
Max drawdown
−44%
past year
ATR
7.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
full year 2026
Revenue
Initiated
$5.16B – $5.21B
prior FY $3.95B
midpoint +31.3% Y/Y
Adjusted gross profit
Non-GAAP
Initiated
$620M – $650M
Adjusted EBITDA
Non-GAAP
Raised
$138M – $163M
second quarter
Revenue
Initiated
$1.3B – $1.32B
prior qtr $1.24B
midpoint +6.1% QoQ
Adjusted gross profit
Non-GAAP
Initiated
$167M – $177M
Adjusted EBITDA
Non-GAAP
Initiated
$50M – $60M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
+4%
Bullish
Price vs 50-day avg
+4%
Bullish
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
61%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
Death cross
50d $19 › 200d $19 — 200d above 50d
Institutional flow
Distributing
4 of 294 funds reported for Jun 30 · net -110.8K sh shares
Insider flow
Distributing
Net -$14.2M over 90 days · 75% sells
Short interest
Falling
11.79% of float · ▼ -4.1% MoM · 4.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
294 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $12
Now $20 · 61%
52-wk high $25
vs 200-day avg +4%
vs 50-day avg +4%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Health plan membership | 284,800 | Q1 FY2026 | — |
|
|
|||
| Medical benefits ratio based on adjusted gross profit non-GAAP | 88.2% | Q1 FY2026 | — |
|
|
|||
| adjusted EBITDA non-GAAP | $38M | Q1 2026 call | — |
| adjusted EBITDA margin non-GAAP | 3.1% | Q1 2026 call | — |
| adjusted gross profit non-GAAP | $146M | Q1 2026 call | — |
| adjusted MBR non-GAAP | 88.2% | Q1 2026 call | — |
| adjusted SG&A non-GAAP | $108M | Q1 2026 call | — |
| adjusted SG&A as a percentage of revenue non-GAAP | 8.7% | Q1 2026 call | — |
| funded leverage ratio | 2.6 | Q1 2026 trailing 12-month call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALHC
this stock
Alignment Healthcare, Inc.
|
$4.10B | +0.4% | +27.2% | 198.3 | 11.8% |
|
UNH
Unitedhealth Group Inc
|
$385.62B | +29.6% | +11.8% | 32.0 | 2.0% |
|
CVS
CVS HEALTH Corp
|
$132.89B | +32.3% | +10.9% | 45.7 | 1.6% |
|
ELV
Elevance Health, Inc.
|
$90.39B | +19.5% | +9.4% | 17.6 | 2.8% |
|
CI
Cigna Group
|
$77.63B | +7.2% | +11.2% | 12.4 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALHC | -16.7% | -3.6% | -11.9% | -16.7% | +0.4% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -18.1% | -7.6% | -20.9% | -17.8% | -10.3% |